Eckert & Ziegler Strahlen- und Medizintechnik AG

Earnings Release • Aug 7, 2007

News Details

Corporate | 7 August 2007 07:40

Eckert & Ziegler: Revenue Growth, Stable Earnings

ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 7 August 2007. Eckert & Ziegler Strahlen- und Medizintechnik AG
(ISIN DE0005659700), a globally active specialist for radioactive
applications in medicine, science and industry with a focus on cancer
radiation systems and measurement technology, increased its sales revenues
for the half year by 14% to 26.5 million EUR. The EBIT for the first six
months of 2007 rose to 2.9 million EUR (+14%), net income however remained
at 0.46 EUR per share (previous half year: 0.45 EUR) due to tax adjustments
and a lower income contribution from low tax countries.

The Radiopharmaceutical segment showed the strongest growth in the half
year with an in-crease in sales of 30% over last year's period, to 3.1
million EUR. Sales in the Therapy seg-ment rose by 19% to 10.4 million EUR.
Due to outstanding developments in industrial products and raw isotopes,
sales in the Nuclear Imaging and Industry segment grew by 8% to 12.9
mil-lion EUR, despite the unfavorable progression of the exchange rate with
the dollar.

The development shown by the business year thus far meets the expectations
of the Board, with the result that the Board continues to anticipate a
result of 2.8 million EUR (0.90 EUR per share) before special and one-time
effects for the 2007 business year. Due to the 2008 German corporate tax
reform, however, a non-monetary burden of 0.8 million EUR (0.25 EUR per
share) is expected. Further details on the interim results will be provided
in the quarterly report to be released today.

The Board

Your contact:

Eckert & Ziegler AG
Thomas Scheuch
Investor Relations
Robert-Rössle-Str. 10
D-13125 Berlin
phone: +49 (0) 30 / 94 10 84-138
fax: +49 (0) 30 / 94 10 84-112
e-mail: thomas.scheuch@ezag.de
www.ezag.de

DGAP 07.08.2007

Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices:
Listed: Geregelter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf

End of News DGAP News-Service

---